Techfields Inc.
- Biotech or pharma, therapeutic R&D
Techfields Inc. is a clinical-stage pharmaceutical company focused on novel transdermal technology platform with long-acting and targeting effects, and high skin penetration/bioavailability to improve the therapeutic effects and safety of biologics and drugs. Our novel technology platform enhances experimental or clinically approved drugs for rapid transdermal penetration into target tissues or systemic circulation. This technology is applicable across multiple therapeutic areas, including Osteoarthritis. Techfields has received a Fast Track designation for its first pipeline product addressing pain in osteoarthritis from US FDA. A Phase 3 clinical trial of X0002 has currently been completed (The clinical study report is pending.) in the US with good safety and efficacy.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}